Interleukin-33/ST2 Axis as Potential Biomarker and Therapeutic Target in Kawasaki Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interleukin-33/ST2 Axis as Potential Biomarker and Therapeutic Target in Kawasaki Disease

Published:2022-10-08 Issue:1 Volume:46 Page:480-490
ISSN:0360-3997
Container-title:Inflammation
language:en
Short-container-title:Inflammation

Author:

Okada Seigo^ORCID,Yasudo Hiroki,Ohnishi Yuji,Matsuguma Chie,Fukano Reiji,Motonaga Takahiro,Waniishi Takako,Hasegawa Shunji

Funder

Japan Society for the Promotion of Science

Japan Agency for Medical Research and Development

Inokuma Prize

Japan Blood Products Organization

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s10753-022-01753-7.pdf

Reference46 articles.

1. Hara, T., K. Yamamura, and Y. Sakai. 2021. The up-to-date pathophysiology of Kawasaki disease. Clinical & Translational Immunology 10: e1284. https://doi.org/10.1002/cti2.1284.

2. Fukazawa, R., J. Kobayashi, M. Ayusawa, H. Hamada, M. Miura, Y. Mitani, E. Tsuda, H. Nakajima, H. Matsuura, K. Ikeda, K. Nishigaki, H. Suzuki, K. Takahashi, K. Suda, H. Kamiyama, Y. Onouchi, T. Kobayashi, H. Yokoi, K. Sakamoto, M. Ochi, S. Kitamura, K. Hamaoka, H. Senzaki, T. Kimura, and Japanese Circulation Society Joint Working Group. 2020. JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease. Circulation Journal 84: 1348–1407. https://doi.org/10.1253/circj.CJ-19-1094.

3. McCrindle, B.W., A.H. Rowley, J.W. Newburger, J.C. Burns, A.F. Bolger, M. Gewitz, A.L. Baker, M.A. Jackson, M. Takahashi, P.B. Shah, T. Kobayashi, M.H. Wu, T.T. Saji, E. Pahl, American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, and Council on Epidemiology and Prevention. 2017. Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135: 927–999. https://doi.org/10.1161/CIR.0000000000000484.

4. Hara, T., Y. Nakashima, Y. Sakai, H. Nishio, Y. Motomura, and S. Yamasaki. 2016. Kawasaki disease: A matter of innate immunity. Clinical and Experimental Immunology 186: 134–143. https://doi.org/10.1111/cei.12832.

5. Kusuda, T., Y. Nakashima, K. Murata, S. Kanno, H. Nishio, M. Saito, T. Tanaka, K. Yamamura, Y. Sakai, H. Takada, T. Miyamoto, Y. Mizuno, K. Ouchi, K. Waki, and T. Hara. 2014. Kawasaki disease-specific molecules in the sera are linked to microbe-associated molecular patterns in the biofilms. PLoS ONE 9: e113054. https://doi.org/10.1371/journal.pone.0113054.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Necrotic Change of Tunica Media Plays a Key Role in the Development of Coronary Artery Lesions in Kawasaki Disease;Circulation Journal;2024-08-06

2. Impact of Helicobacter pylori and metabolic syndrome-related mast cell activation on cardiovascular diseases;Frontiers in Gastroenterology;2024-03-04

3. 川崎病新規バイオマーカーおよび治療標的としてのインターロイキン33／ST2系;Yamaguchi Medical Journal;2023-11-27

4. Transient anti-cytokine autoantibodies superimpose the hyperinflammatory response in Kawasaki disease and multisystem inflammatory syndrome in children: a comparative cohort study on correlates of disease;eBioMedicine;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3